Navigation Links
White Smile Global Inc. Corporate Update on the White Smile Premier™ "At-Home" LED Teeth Whitening System and the White Smile Tooth Gloss™, Including Clinical Study, Product Manufacturing, and Distribution
Date:11/16/2011

MIAMI BEACH, Fla., Nov. 16, 2011 /PRNewswire/ -- White Smile Global Inc. (OTCBB: WSML) is excited to offer existing and potential share holders an update on the Company.

Upon appointment of Chief Scientific Officer and Board Member Dr. Martin S. Giniger DMD, PhD, MsD, FICD, the Company has recently announced several Patent-Pending Oral Health and Teeth Whitening Technologies that have been purchased in full from the world renowned Bio-Chemist. Upon acquisition of these products, White Smile Global Scientific Team, led by Dr. Giniger, closed in on strategic partnerships with FDA Registered Laboratories within the United States.  One such laboratory is June Jacobs Laboratory which operates an approximate 50,000 sq.ft. advanced manufacturing facility in the North Eastern United States.  White Smile Global Inc. also announced shortly after that the Chief Operations Officer of June Jacobs Laboratories, Mr. Matthew Silpe, was elected to the Company's Board of Directors.  Also an announcement was made appointing Dr. Marcus S. Tappan DMD to the board of Scientific Advisors.

Recently completed is the White Smile Premier™ "At-Home" Professional Grade LED Teeth Whitening System which consists of a handheld Professional Grade LED teeth whitening light paired with a two part pen system and the revolutionary White Smile™ Tooth Gloss.  Several of the components in this new system, which is designed for use at home or "on-the-go," utilize patent-pending formulations of Dr. Giniger's inventions.

Clinical Study on this product is nearing completion, with preliminary results exceeding the Company's expectations.  Preliminary product packaging design has been recently completed and will be finalized upon receiving the final results of the clinical study at which time White Smile Global will make the results of the final claims before the product becomes available for purchase to consumers.

Also created was the packaging for the "EU-Friendly" Non-Peroxide version of the Smile Premier™ "At-Home" Professional Grade LED Teeth Whitening System which will make this product the first "At-Home" LED Teeth Whitening System available to consumers in the European Union market due to the cutting edge technology of the patent-pending micro-encapsulated teeth whitening gel created by Dr. Giniger. French Distributor, Institut Saint Paul, has already presented this product to its distribution channels in France, Italy, and other European Countries with very positive feedback.  Samples of the new packaging have been approved by both the Company's Board of Directors as well as the Distributor and mass manufacturing has commenced.

White Smile Global will be introducing additional Distributors in multiple countries in Asia, Europe, Africa, and South Africa in the following weeks as the Company's Executives finalized details with these potential International Partners.

About White Smile Global Inc.

White Smile Global Inc. is a vertically integrated Oral Health and Teeth Whitening Company that was created with the intent of offering the most effective, cutting edge technologies to the Cosmetic Dental Industry both domestically and abroad. Through countless hours of both product and market research, our team has created the next phase in this ever expanding multi-billion dollar industry. The Company owns and operates the White Smile™ brand which includes multiple patent-pending formulas that are set to be released to the general public through retail product placement and online sales beginning this fourth quarter of 2011.  All White Smile™ Products are designed and Manufactured in FDA Registered Laboratories within the United States of America.

For more information please contact:
White Smile Global Inc. - Toll Free:  1.888.WSMILE1      
General Information:  info@whitesmileglobal.com

FORWARD LOOKING STATEMENT

This announcement is not an offer to sell any White Smile Global ("WSML") or related securities. Offers for any given security are made only through applicable offering circulars and related documents filed with the SEC pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934. Certain statements contained herein and subsequent oral statements made by and on behalf of WSML may contain "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements are identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and includes, without limitation, statements regarding WSML's plan of business operations, product research and development activities, anticipated revenues and expenses and potential contractual arrangements and obligations. Also, our management may make forward-looking statements orally to investors, analysts, the media and others. Forward-looking statements express our expectations or predictions of future events or results. They are not guarantees and are subject to many risks and uncertainties. There are a number of factors beyond our control that could cause actual events or results to be significantly different from those described in the forward-looking statements. Any or all of our forward-looking statements in this report or in any other public statements we make may turn out to be wrong. We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE White Smile Global Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
2. AHF Seeks White House Clarification After Press Room Flap Over CDCs HIV Numbers
3. White Nose Syndrome: Is Pennsylvania Next?
4. White Paper Explains Aspects of Testing From Purified Bulk Drug Substance to Sterile Liquid Final Drug Product
5. ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
6. Society of Gynecologic Oncologists Issues White Paper on HPV Vaccines Impact on Cervical Cancer Prevention
7. BIA Publishes White Paper: ISO 9000 Role in Document Review, Emphasizes Quality Equals Defensibility
8. Whitepaper From Mirial Explains how Visual Communication Technology can Improve Healthcare Services
9. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
10. Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases
11. Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... study highlights the necessity of health literacy within the technology advancement of diagnostic imaging. According ... , a majority of oncology patients undergo imaging screenings without understanding the nuanced risks ... ... ... Medical Diagnostic Imaging Ampronix ...
(Date:5/27/2016)... , May 27, 2016 ... biopharmaceutical company focused on late-stage drug development, today ... Pharma of pivotal batches required for registration ... Administration (FDA). This follows Kitov,s announcement ... trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... 26, 2016 A key trend ... the emergence of new treatments. Cardax, a development stage ... treatment. The therapy is expected to fulfil large unmet ... is conducting studies to develop new treatments for osteoarthritis. ... genes involved in osteoarthritis are being investigated, and early ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... ... More than a third of American adults are considered obese, says the ... increased attention in recent years, as an article published May 18th on ... people are familiar with the basic requirements of maintaining a healthy diet and exercise ...
(Date:5/27/2016)... ... 2016 , ... With over 60 percent of acute stroke survivors being left ... to aid in the rehabilitation process has steadily increased. Ekso Bionics had been working ... due to stroke. , Ekso Bionics has now received clearance from the U.S. Food ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 ... ... care world, this installment is bolstered by inspiring human interest stories, courtesy of ... the developing trends and tech within the industry, from leading advocates and associations—namely ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research ... their dogs straight off the grill. Of the 90 percent of Americans who say ... a hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its Connor Cares ... the Tamika Catchings Legacy Tour that will commemorate the Indiana Fever legend’s ... surfaces in all forms and levels of the game, Connor Sports has committed to ...
Breaking Medicine News(10 mins):